Frequently Asked Questions What blood tests should be checked while taking semaglutide
Most RCTs failed to demonstrate a significant association between GLP-1 RAs and the occurrence of pancreatitis or pancreatic cancer, primarily because of their short duration and insufficient design for evaluating such risks
Trends can help distinguish a temporary fluctuation from a sustained change that deserves follow-up
A licensed healthcare provider will review your health and medical history to determine if you qualify for GLP-1 treatment and discuss your options with you before prescribing medication
At Elite Primary Care Group, we understand that every patient is unique
Retatrutide, as the newest and most advanced triple-agonist metabolic peptide, sits at the higher end of the research peptide pricing range but the gap between the cheapest Canadian retatrutide and the most expensive isn't arbitrary, and it's not always proportional to quality